Sigma Healthcare Ltd(SIGGF)
$1.98+0.09 (+4.76%)
SIGGF
Sigma Healthcare Ltd financials statements
$1.98
At close:+0.09 (+4.76%)
Sigma Healthcare Ltd (SIGGF) Ratios
9 Followers
Sigma Healthcare Ltd Ratios
SIGGF's free cash flow for Q2 2027 was AU$224.42M. For the 2027 fiscal year, SIGGF's free cash flow was decreased by AU$-33.25M and operating cash flow was AU$257.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.67 | 1.59 | 2.46 | 1.44 | 1.66 |
| Quick Ratio | 1.06 | 1.15 | 1.86 | 0.76 | 0.96 |
| Cash Ratio | 0.06 | 0.02 | 0.96 | 0.03 | 0.07 |
| Solvency Ratio | 0.20 | 0.01 | 0.06 | 0.04 | 0.03 |
| Operating Cash Flow Ratio | 0.28 | -0.36 | 0.11 | 0.30 | -0.10 |
| Short-Term Operating Cash Flow Coverage | 13.64 | -8.85 | 4.29 | 38.78 | -3.01 |
| Net Current Asset Value | AU$ -492.01M | AU$ 385.50M | AU$ 380.98M | AU$ -37.99M | AU$ -25.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.07 | 0.10 | 0.19 | 0.25 |
| Debt-to-Equity Ratio | 0.40 | 0.16 | 0.16 | 0.48 | 0.66 |
| Debt-to-Capital Ratio | 0.29 | 0.14 | 0.14 | 0.32 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.51 | 0.00 | 0.14 | 0.25 |
| Financial Leverage Ratio | 1.78 | 2.18 | 1.61 | 2.52 | 2.62 |
| Debt Service Coverage Ratio | 5.03 | 0.58 | 1.91 | 2.64 | 1.23 |
| Interest Coverage Ratio | 8.74 | -0.54 | -4.41 | -4.78 | -10.16 |
| Debt to Market Cap | 0.03 | 0.20 | 0.01 | 0.15 | 0.44 |
| Interest Debt Per Share | 0.19 | 0.10 | 0.15 | 0.24 | 0.33 |
| Net Debt to EBITDA | 1.74 | 2.12 | -4.13 | 4.19 | 9.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.06% | 6.83% | 5.71% | 6.12% | 5.79% |
| EBIT Margin | 9.21% | 0.61% | 0.75% | 0.54% | 0.07% |
| EBITDA Margin | 10.00% | 1.13% | 1.60% | 1.37% | 0.88% |
| Operating Profit Margin | 9.21% | -0.21% | -2.17% | -1.88% | -3.20% |
| Pretax Profit Margin | 9.28% | 0.23% | 0.26% | 0.15% | -0.24% |
| Net Profit Margin | 6.55% | -0.28% | 0.14% | 0.05% | -0.21% |
| Continuous Operations Profit Margin | 6.54% | 10.74% | 0.16% | 0.08% | -0.18% |
| Net Income Per EBT | 70.56% | -124.19% | 52.28% | 33.16% | 87.14% |
| EBT Per EBIT | 100.71% | -110.56% | -11.99% | -7.92% | 7.54% |
| Return on Assets (ROA) | 7.96% | -0.76% | 0.32% | 0.15% | -0.57% |
| Return on Equity (ROE) | 14.20% | -1.65% | 0.52% | 0.38% | -1.49% |
| Return on Capital Employed (ROCE) | 14.55% | -1.04% | -6.97% | -9.52% | -13.47% |
| Return on Invested Capital (ROIC) | 9.96% | 1.15% | -4.21% | -5.18% | -9.96% |
| Return on Tangible Assets | 14.02% | -0.80% | 0.35% | 0.18% | -0.69% |
| Earnings Yield | 2.24% | -0.31% | 0.43% | 0.32% | -1.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.40 | 5.14 | 10.48 | 11.01 | 9.61 |
| Payables Turnover | 6.83 | 6.28 | 10.33 | 8.46 | 9.22 |
| Inventory Turnover | 7.13 | 11.89 | 14.16 | 10.58 | 10.09 |
| Fixed Asset Turnover | 19.91 | 19.11 | 12.22 | 12.58 | 12.24 |
| Asset Turnover | 1.22 | 2.67 | 2.37 | 3.05 | 2.70 |
| Working Capital Turnover Ratio | 11.48 | 9.29 | 8.86 | 14.28 | 14.28 |
| Cash Conversion Cycle | 65.37 | 43.60 | 25.25 | 24.53 | 34.55 |
| Days of Sales Outstanding | 67.59 | 71.06 | 34.84 | 33.15 | 37.99 |
| Days of Inventory Outstanding | 51.22 | 30.69 | 25.77 | 34.51 | 36.16 |
| Days of Payables Outstanding | 53.44 | 58.14 | 35.35 | 43.13 | 39.60 |
| Operating Cycle | 118.81 | 101.75 | 60.60 | 67.66 | 74.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | -0.20 | 0.04 | 0.14 | -0.05 |
| Free Cash Flow Per Share | 0.05 | -0.21 | 0.04 | 0.11 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 1.32 | -12.60 | 2.85 | 3.22 | -1.36 |
| Capital Expenditure Coverage Ratio | 10.13 | -39.90 | 8.89 | 4.86 | -3.26 |
| Operating Cash Flow Coverage Ratio | 0.28 | -2.39 | 0.31 | 0.63 | -0.14 |
| Operating Cash Flow to Sales Ratio | 0.05 | -0.06 | 0.01 | 0.04 | -0.01 |
| Free Cash Flow Yield | 1.64% | -7.17% | 3.53% | 19.72% | -14.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 44.57 | -326.14 | 234.02 | 317.28 | -56.14 |
| Price-to-Sales (P/S) Ratio | 2.92 | 0.92 | 0.32 | 0.16 | 0.12 |
| Price-to-Book (P/B) Ratio | 6.33 | 5.38 | 1.21 | 1.21 | 0.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 61.07 | -13.94 | 28.33 | 5.07 | -6.72 |
| Price-to-Operating Cash Flow Ratio | 55.05 | -14.29 | 25.14 | 4.03 | -8.78 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 1.09 | 1.62 | -2.53 | 0.48 |
| Enterprise Value Multiple | 30.95 | 83.43 | 15.69 | 15.63 | 23.12 |
| Enterprise Value | 33.52B | 4.63B | 835.32M | 784.93M | 698.71M |
| EV to EBITDA | 30.95 | 83.43 | 15.69 | 15.63 | 23.12 |
| EV to Sales | 3.09 | 0.95 | 0.25 | 0.21 | 0.20 |
| EV to Free Cash Flow | 64.72 | -14.31 | 22.43 | 6.93 | -11.55 |
| EV to Operating Cash Flow | 58.33 | -14.66 | 19.91 | 5.50 | -15.10 |
| Tangible Book Value Per Share | 0.10 | 0.46 | 0.75 | 0.26 | 0.25 |
| Shareholders’ Equity Per Share | 0.43 | 0.53 | 0.85 | 0.47 | 0.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 2.16 | 0.38 | 0.45 | 0.24 |
| Revenue Per Share | 0.94 | 3.11 | 3.24 | 3.58 | 3.38 |
| Net Income Per Share | 0.06 | -0.01 | 0.00 | 0.00 | -0.01 |
| Tax Burden | 0.71 | -1.24 | 0.52 | 0.33 | 0.87 |
| Interest Burden | 1.01 | 0.38 | 0.35 | 0.27 | -3.28 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.06 | 0.03 | 0.02 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | 0.00 | -0.25 | 0.00 | 78.82 | 6.39 |
Currency in AUD
